Targeting Refractory Cancer
Dr. James LaBelle, assistant professor of pediatrics, is focusing his research on using parts of natural proteins to induce cell death in cancers that are completely refractory to conventional chemotherapy.
Published
February 29, 2016
Created by
Related Presenters
Assistant Professor of Pediatrics
James LaBelle, MD, PhD, provides care for children of all ages with cancer and blood diseases, including leukemia and lymphoma. In particular, Dr. LaBelle specializes in stem cell transplantation, replacing a patient's diseased bone marrow ...